BeOne Medicines Ltd ADR

ONCNASDAQ · USD
360.85USD0.00 (+0.25%)
569

BeOne Medicines Ltd ADR (ONC) Options Open Interest

ONC options open interest is 1,389 contracts. The 2-week average daily volume is 69 contracts across the chain.

Read more

Monitoring ONC open interest helps you see where real money is positioned on BeOne Medicines Ltd ADR's options and which strikes are attracting the most commitment from traders. BeOne Medicines Ltd ADR's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ONC options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ONC options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect BeOne Medicines Ltd ADR to settle.

BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in late 2024 and redomiciled to Basel, Switzerland in 2025. BeOne has established itself as a leader in immuno-oncology and targeted therapies, with key assets including Tevimbra (tislelizumab), a PD-1 monoclonal antibody approved for multiple cancer indications globally, and Brukinsa (zanubrutinib), a Bruton's tyrosine kinase (BTK) inhibitor that surpassed $1.3 billion in annual sales and is approved in major markets such as the U.S., Europe, and China.

The company’s strategy combines internal R&D with the development of assets sourced from external partnerships, driving a robust pipeline across hematologic malignancies and solid tumors.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ONC open interest is concentrated. Our scanner maps BeOne Medicines Ltd ADR's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade BeOne Medicines Ltd ADR's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
310.0050.2054.3052.2540%+0.953238
320.0040.7044.9042.8038%+0.920438
400.001.004.402.7040%+0.156530
460.00—3.803.8080%+0.121416
390.001.005.303.1535%+0.195412
Puts
340.001.805.703.7534%-0.213715
330.000.154.702.4337%-0.14172
360.009.3012.5010.9034%-0.46102
300.00—1.201.2052%-0.05911
310.00—5.005.0068%-0.15191

As of September 25, 2026

Follow the money

Track ONC open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial